Gi Emergency

Download as key, pdf, or txt
Download as key, pdf, or txt
You are on page 1of 29

GI EMERGENCY

Common GI
EMERGENCIES

UGI BLEED
HEPATIC ENCEPHALOPATHY
LIVER FAILURE
DILI
UGI BLEED

BLEEDING FROM ANYWHERE BETWEEN ORAL CAVITY TO DUODENUM


Manifesting as:

Hematemesis
Malena
Hematochezia
1. PUD
2. Esophageal or Gastric varix
3. Portal hypertension related lesion
4. Esophagitis
5. Angiectasia
6. Mallory Weiss tear
7. Dieulafoy lesion
8. Neoplasm
Management of UGI BLEED

RESUSCITAION:
2 large bore canuula(14 or 16G)
Infuse normal saline to keep HR<100 and SBP>100
Target to keep Hb>7, Plt>50,000, PT<15. In CAD target Hb is 9

ET Intubation:
Ongoing bleed
Altered sensorium
Respiratory insufficiency
Initial medical management

PPI: 80mg stat followed by 8mg per hour infusion


VASOPRESSORS: Octreotide or terlipressin
Antibiotics in cirrhotic UGI Bleed
IV Metoclopramide 30 t0 90 min before UGI endoscopy
Saline lavage with orogastric tube help to evacuate blood clots

Timing of Endoscopy:
Hemodynamicalyy stable patient: with in 24 hours
Unstable but resuscitable: with in 12 hours in ICU
Unstable: with in 6 hours in OT
Esophageal Varices
Treatment of PUD:
1a, 2a, 2b: inj Epinephrine with hemoclip
1b and 2c inj Epinephrine is sufficient.
3 no endoscopic therapy required

Treatment of Esophageal Varices:


Endoscopic band ligation
Hepatic Encephalopathy
Classification of HE

TIME COURSE:
Episodic
Recurrent
Persistent

SPONTANEOUS OR PRECIPITATED

TYPES OF HE:
A: ALF
B: Portosystemic bypass
C: Cirrhosis or portal hypertension
Precipitating factors of HE

Infection
GI Bleed
Constipation
Electrolyte abnormalities
Dehydration - diuretics
Excessive dietary protein
Hypoglycemia
Anemia etc
Treatment of HE

Treatment of precipitating factors


Lactulose
Enema
Rifaximin
Acarbose
Probiotics
Zinc
Others: sodium benzoate, LOLA
Acute Liver Failure

Acute severe deterioration of liver function

Jaundice: 3mg/dl

Coagulopathy Altered sensorium


Mortality: 40-90% if untreated
3 phases of acute liver failure:
Prodromal phase
Icteric phase
Hepatic encephalopathy

Duration: 3 months, from onset of symptoms to hepatic encephalopathy.


Classification based on the duration:
From the onset of jaundice to HE interval
Hyperacute: <7 days
Acute: 1 week to 1 month
Subacute: 1 - 6 months
Chronic Liver disease: >6 months
Causes of ALF
Complications of ALF

Neurological: Encephalopathy, intracranial hypertension and cerebral edema, brain herniation


and death
Hemodynamic changes and circulatory failure
Infections
Acute kidney injury: pre renal issues due to GI bleed, dehydration, direct injury due to bile
salts causing AKI, sepsis
Hematologic abnormalities: both bleeding and hypercoagulable state
Management of ALF
ICP MONITRING:
Patients with hyperacute and acute presentation with ammonia level : 150-200
Renal impairment
Vasopressor support
Sensorium not improving on mannitol, hypertonic saline, or after hyperventilation or
hypothermia.
Methods to modulate central blood flow:
Elevate head of bed by 20-30 degrees
Correct volume overload
Maintain MAP 50-60 mmhg
Hyperventilation to keep PaCO2 low
Correct factors that increase ICP:
Minimize head turning
Treat agitation by paralyzing with intubation and sedation
Treat hypotension
Monitor seizures
Correct hypoxemia
Direct measures:
Correct hypo osmolarity
Mannitol (0.5-1g/kg bw) iv bolus
Induce hypernatremia: Na: 150-155
Liver Transplantation
Antidotes

Paracetamol: NAC
HBV: Tenofovir
Amanita: Silymarinb/penicillin
Herpes Simplex: Acyclovir
Lassafever, Yellow fever: Ribavarin
Autoimmune hepatitis: steroids
Wilsons: high dose peniccin or doxyxline
Leptospirosis: penicillin or doxycycline
Other Treatment: fluid and electrolyte, acid base disturbances and Nutrition
Acetaminophen/Paracetamol toxicity treatment

MCC of drug induced ALF in west


Its an intrinsic hepatotoxin
<4g /day: safe, upto 2g per day in CLD
presents with hyperacute LF with high cerebral edema, high coagulopathy
Features of injury starts from day 3, >AST/ALT while Bilurubin lebel are lower
Centrilobular (zone 3) necrosis
AKI seen in 70% cases, direct tubulotoxic
15g: hepatotoxicity
>20g: consistent with ALF
Liver Transplantation

Not all patients require liver


Contraindications are:
Prolonged raised ICP >40mmhg
MODS with sepsis
Malignancy
Strict indications are needed:
30% operative moratlity
Require lifelong immunosuppressants
Source of liver is scarce
Indications and contraindications of liver transplantation
Hepatic/primary ALF
Drug related
Acute viral hepatitis
Budd-Chiari syndrome
Autoimmune
Pregnancy related
Extrahepatic/secondary
Hypoxic hepatitis-aka ischemic
Lymphoma
Infections- malaria
Infiltrative diseases etc
Criteria for Liver Transplantation

Kings college
Clichy criteria
APACHE Score
Liver Biopsy
Serum lactate
DILI

Toxins can be:


Industrial toxins
Pharmacological agents
Complimentary and alternative medicines
Hepatic injury can be:
Direct injury
Immune response to the agent
DILI can be suspected when:
ALT >5xULN without symptoms
ALT >3xULN with symptoms or TB> 2xULN
ALP >2xULN
Pattern of liver injury
R Ratio: ALT/ ULN of ALT/ ALP/ ULN of ALP
Hepatocellular: >5
Cholestatic: </=2
Mixed: 2-5
Mechanisms of Liver Injury
Alterations in Hepatic morphology produced by some commonly used drugs
Cholestasis: rifampicin, nitrofurantoin, carbamazepine, TCAs, clopidogrel, nefidipine,
lisinopril
Fatty liver: amiodarone, valoproate
Hepatitis: halothane, isoniazid, flucanazole, phenytoin, indomethacin, chlorthiazide,
methyldopa
MeIxed: amoxicillin-clavulunate, cotrimaxazole, clindamycin, azathiprine
Toxic (Necrosis): paracetamol, carbon tetrachloride, yellow phosphorus, amanita phalloides
Granulomas: quinidine, sulfonamides, carbamazepine, allopurinol
Vascular injury: oxaliplatin, melphalan

You might also like